Agile Therapeutics Inc

CIK 1261249 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Agile Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Nov 13, 2024SC 13G/A0000935836-24-000658
Sep 30, 202415-12G0001104659-24-104089
Aug 28, 2024RW0001104659-24-093742
Aug 27, 2024EFFECT9999999995-24-002644
Aug 27, 2024EFFECT9999999995-24-002645
Aug 27, 2024EFFECT9999999995-24-002643
Aug 26, 202440001104659-24-092946
Aug 26, 202440001104659-24-092938
Aug 26, 2024POS AM0001104659-24-092916
Aug 26, 2024S-8 POS0001104659-24-092926
Aug 26, 202440001104659-24-092947
Aug 26, 202440001104659-24-092942
Aug 26, 2024S-8 POS0001104659-24-092928
Aug 26, 20248-K0001104659-24-092914
Aug 26, 2024POS AM0001104659-24-092921
Aug 26, 2024S-8 POS0001104659-24-092925
Aug 26, 2024SCHEDULE 13G0002034373-24-000001
Aug 26, 202440001104659-24-092944
Aug 26, 2024POS AM0001104659-24-092918
Aug 26, 2024S-8 POS0001104659-24-092930
Aug 26, 202440001104659-24-092937
Aug 26, 2024S-8 POS0001104659-24-092923
Aug 26, 202440001104659-24-092933
Aug 26, 202440001104659-24-092940
Aug 26, 202440001104659-24-092945